The Trump administration has launched another aggressive assault on alleged Medicare fraud, with federal officials saying more than $1.6 billion in potentially improper laboratory payments has been blocked or clawed back since President Donald J. Trump took office. The crackdown has also seen 157 laboratory providers removed from Medicare, as officials turn increasingly to data analytics and artificial intelligence to identify suspicious claims before taxpayers’ money disappears into the healthcare Bermuda Triangle.
The figures arrive amid a broader federal healthcare-fraud campaign. The Department of Justice said its 2026 National Health Care Fraud Takedown involved 455 defendants and more than $6.5 billion in alleged fraud, including schemes involving medically unnecessary or nonexistent laboratory testing.
The Labs Fraud That Medicare Could Not Find
According to the reported CMS findings, some laboratories allegedly developed an unusual business model: collect Medicare money first and worry about the laboratory part later. In one case, a consulting-company owner enrolled 14 laboratories and billed Medicare more than $24 million, although CMS said none of the facilities appeared to be operating. Federal officials subsequently held back $12 million and recovered another $7 million, while 11 of those laboratories were removed from Medicare and three remained under investigation.
For taxpayers, the episode offers a rather uncomfortable medical diagnosis: the paperwork was apparently healthier than the laboratories. CMS says it is using artificial intelligence to examine claims for unusual patterns, allowing suspicious bills to be stopped, rejected or denied before payment. The agency’s wider program-integrity campaign has reported record savings, with CMS saying Medicare program-integrity savings reached $41.9 billion in fiscal 2025.
AI Joins the Hunt for the Medicare Money
The laboratory crackdown is not happening in isolation. Federal prosecutors have continued bringing cases involving allegedly unnecessary genetic testing and false laboratory claims. In February, the Justice Department announced the conviction of a Texas laboratory owner and former NFL player in a $328 million genetic-testing fraud scheme, while another Florida laboratory owner pleaded guilty in January in a case involving more than $52 million in allegedly fraudulent genetic-testing claims.
And the government’s message appears increasingly straightforward: if a laboratory cannot demonstrate that the test was performed, medically necessary and properly billed, Medicare’s cheque may be heading nowhere. CMS has separately described healthcare fraud as a major target of its affordability and program-integrity agenda, while its Medicaid Fraud War Room reported stopping more than $203 million in potentially improper payments in its first 88 days through coordinated enforcement and data analytics.
For the moment, the biggest lesson from the laboratory crackdown is that Medicare’s money may finally be getting a more suspicious pair of eyes—and apparently an electronic one at that. Whether AI can stay ahead of increasingly creative billing schemes will be worth watching, especially as federal investigators continue examining laboratories, claims and the people behind them. OGM News will continue to watch the crackdown and bring readers further updates as the Medicare fraud story develops.
[…] […]